Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan.

Filippo Pietrantonio; Federica Morano; Monica Niger; Salvatore Corallo; Maria Antista; Alessandra Raimondi; Michele Prisciandaro; Filippo Pagani; Natalie Prinzi; Federico Nichetti; Giovanni Randon; Martina Torchio; Francesca Corti; Margherita Ambrosini; Federica Palermo; Michele Palazzo; Lavinia Biamonte; Marco Platania; Carlo Sposito; Maurizio Cosimelli; Vincenzo Mazzaferro; Sara Pusceddu; Chiara Cremolini; Filippo de Braud; Maria Di Bartolomeo

Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan.

Filippo Pietrantonio, Federica Morano, Monica Niger, Salvatore Corallo, Maria Antista, Alessandra Raimondi, Michele Prisciandaro, Filippo Pagani, Natalie Prinzi, Federico Nichetti, Giovanni Randon, Martina Torchio, Francesca Corti, Margherita Ambrosini, Federica Palermo, Michele Palazzo, Lavinia Biamonte, Marco Platania, Carlo Sposito, Maurizio CosimelliVincenzo Mazzaferro, Sara Pusceddu, Chiara Cremolini, Filippo de Braud, Maria Di Bartolomeo

Fondazione IRCCS Istituto Nazionale dei Tumori

Research output: Contribution to journal › Article › peer-review

Abstract

The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak poses a major challenge in the treatment decision-making of patients with cancer, who may be at higher risk of developing a severe and deadly SARS-CoV-2 infection compared with the general population. The health care emergency is forcing the reshaping of the daily assessment between risks and benefits expected from the administration of immune-suppressive and potentially toxic treatments. To guide our clinical decisions at the National Cancer Institute of Milan (Lombardy region, the epicenter of the outbreak in Italy), we formulated Coronavirus-adapted institutional recommendations for the systemic treatment of patients with gastrointestinal cancers. Here, we describe how our daily clinical practice has changed due to the pandemic outbreak, with the aim of providing useful suggestions for physicians that are facing the same challenges worldwide.

Original language	English
Journal	Clinical Colorectal Cancer
Issue number	3
Publication status	Published - Sep 1 2020

Fingerprint Dive into the research topics of 'Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan.'. Together they form a unique fingerprint.

Cite this

Pietrantonio, F., Morano, F., Niger, M., Corallo, S., Antista, M., Raimondi, A., Prisciandaro, M., Pagani, F., Prinzi, N., Nichetti, F., Randon, G., Torchio, M., Corti, F., Ambrosini, M., Palermo, F., Palazzo, M., Biamonte, L., Platania, M., Sposito, C., ... Di Bartolomeo, M. (2020). Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan. Clinical Colorectal Cancer, (3).

Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan. / Pietrantonio, Filippo; Morano, Federica ; Niger, Monica ; Corallo, Salvatore ; Antista, Maria; Raimondi, Alessandra; Prisciandaro, Michele; Pagani, Filippo; Prinzi, Natalie; Nichetti, Federico; Randon, Giovanni; Torchio, Martina; Corti, Francesca; Ambrosini, Margherita; Palermo, Federica; Palazzo, Michele; Biamonte, Lavinia; Platania, Marco ; Sposito, Carlo ; Cosimelli, Maurizio ; Mazzaferro, Vincenzo ; Pusceddu, Sara; Cremolini, Chiara; de Braud, Filippo ; Di Bartolomeo, Maria.

In: Clinical Colorectal Cancer, No. 3, 01.09.2020.

Research output: Contribution to journal › Article › peer-review

Pietrantonio, F, Morano, F , Niger, M , Corallo, S , Antista, M, Raimondi, A, Prisciandaro, M, Pagani, F, Prinzi, N, Nichetti, F, Randon, G, Torchio, M, Corti, F, Ambrosini, M, Palermo, F, Palazzo, M, Biamonte, L, Platania, M , Sposito, C , Cosimelli, M , Mazzaferro, V , Pusceddu, S, Cremolini, C, de Braud, F & Di Bartolomeo, M 2020, 'Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan.', Clinical Colorectal Cancer, no. 3.

Pietrantonio, Filippo ; Morano, Federica ; Niger, Monica ; Corallo, Salvatore ; Antista, Maria ; Raimondi, Alessandra ; Prisciandaro, Michele ; Pagani, Filippo ; Prinzi, Natalie ; Nichetti, Federico ; Randon, Giovanni ; Torchio, Martina ; Corti, Francesca ; Ambrosini, Margherita ; Palermo, Federica ; Palazzo, Michele ; Biamonte, Lavinia ; Platania, Marco ; Sposito, Carlo ; Cosimelli, Maurizio ; Mazzaferro, Vincenzo ; Pusceddu, Sara ; Cremolini, Chiara ; de Braud, Filippo ; Di Bartolomeo, Maria. / Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan. In: Clinical Colorectal Cancer. 2020 ; No. 3.

@article{4dcd7328ee6f497694e1f50f9fd667b7,

title = "Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan.",

abstract = "The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak poses a major challenge in the treatment decision-making of patients with cancer, who may be at higher risk of developing a severe and deadly SARS-CoV-2 infection compared with the general population. The health care emergency is forcing the reshaping of the daily assessment between risks and benefits expected from the administration of immune-suppressive and potentially toxic treatments. To guide our clinical decisions at the National Cancer Institute of Milan (Lombardy region, the epicenter of the outbreak in Italy), we formulated Coronavirus-adapted institutional recommendations for the systemic treatment of patients with gastrointestinal cancers. Here, we describe how our daily clinical practice has changed due to the pandemic outbreak, with the aim of providing useful suggestions for physicians that are facing the same challenges worldwide.",

author = "Filippo Pietrantonio and Federica Morano and Monica Niger and Salvatore Corallo and Maria Antista and Alessandra Raimondi and Michele Prisciandaro and Filippo Pagani and Natalie Prinzi and Federico Nichetti and Giovanni Randon and Martina Torchio and Francesca Corti and Margherita Ambrosini and Federica Palermo and Michele Palazzo and Lavinia Biamonte and Marco Platania and Carlo Sposito and Maurizio Cosimelli and Vincenzo Mazzaferro and Sara Pusceddu and Chiara Cremolini and {de Braud}, Filippo and {Di Bartolomeo}, Maria",

year = "2020",

month = sep,

day = "1",

language = "English",

journal = "Clinical Colorectal Cancer",

issn = "1533-0028",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan.

AU - Pietrantonio, Filippo

AU - Morano, Federica

AU - Niger, Monica

AU - Corallo, Salvatore

AU - Antista, Maria

AU - Raimondi, Alessandra

AU - Prisciandaro, Michele

AU - Pagani, Filippo

AU - Prinzi, Natalie

AU - Nichetti, Federico

AU - Randon, Giovanni

AU - Torchio, Martina

AU - Corti, Francesca

AU - Ambrosini, Margherita

AU - Palermo, Federica

AU - Palazzo, Michele

AU - Biamonte, Lavinia

AU - Platania, Marco

AU - Sposito, Carlo

AU - Cosimelli, Maurizio

AU - Mazzaferro, Vincenzo

AU - Pusceddu, Sara

AU - Cremolini, Chiara

AU - de Braud, Filippo

AU - Di Bartolomeo, Maria

PY - 2020/9/1

Y1 - 2020/9/1

N2 - The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak poses a major challenge in the treatment decision-making of patients with cancer, who may be at higher risk of developing a severe and deadly SARS-CoV-2 infection compared with the general population. The health care emergency is forcing the reshaping of the daily assessment between risks and benefits expected from the administration of immune-suppressive and potentially toxic treatments. To guide our clinical decisions at the National Cancer Institute of Milan (Lombardy region, the epicenter of the outbreak in Italy), we formulated Coronavirus-adapted institutional recommendations for the systemic treatment of patients with gastrointestinal cancers. Here, we describe how our daily clinical practice has changed due to the pandemic outbreak, with the aim of providing useful suggestions for physicians that are facing the same challenges worldwide.

AB - The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak poses a major challenge in the treatment decision-making of patients with cancer, who may be at higher risk of developing a severe and deadly SARS-CoV-2 infection compared with the general population. The health care emergency is forcing the reshaping of the daily assessment between risks and benefits expected from the administration of immune-suppressive and potentially toxic treatments. To guide our clinical decisions at the National Cancer Institute of Milan (Lombardy region, the epicenter of the outbreak in Italy), we formulated Coronavirus-adapted institutional recommendations for the systemic treatment of patients with gastrointestinal cancers. Here, we describe how our daily clinical practice has changed due to the pandemic outbreak, with the aim of providing useful suggestions for physicians that are facing the same challenges worldwide.

M3 - Article

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

SN - 1533-0028

IS - 3

ER -